Log in
Enquire now
‌

US Patent 10906991 Bispecific antibodies and methods for production thereof

Patent 10906991 was granted and assigned to Genmab A/S on February, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
‌
Genmab A/S
0
Current Assignee
‌
Genmab A/S
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
109069910
Patent Inventor Names
Jan Van De Winkel0
Janine Schuurman0
Marijn Van Der Neut Kolfschote0
Paul Parren0
Rob Aalberse0
Tom Vink0
Aran Frank Labrijn0
Date of Patent
February 2, 2021
0
Patent Application Number
149349560
Date Filed
November 6, 2015
0
Patent Citations
‌
US Patent 10597464 Heterodimeric antibody Fc-containing proteins and methods for production thereof
0
‌
US Patent 10344050 Production of heterodimeric proteins
Patent Citations Received
‌
US Patent 11492371 Production of heterodimeric proteins
0
‌
US Patent 11535679 Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular lymphoma
0
‌
US Patent 11548952 Bispecific antibody against CD3 and CD20 in combination therapy for treating diffuse large B-cell lymphoma
0
‌
US Patent 11608383 Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular lymphoma
0
‌
US Patent 11261254 Antibodies
0
‌
US Patent 11359015 Humanized or chimeric CD3 antibodies
‌
US Patent 11858995 Bispecific antibodies against CD3 and CD20 for treating chronic lymphocytic leukemia
0
‌
US Patent 11866514 Heterodimeric antibody Fc-containing proteins and methods for production thereof
0
...
Patent Primary Examiner
‌
Brad Duffy
0
Patent abstract

The invention relates to an ex vivo method for the generation of a bispecific antibody, comprising the steps of: a) providing a first antibody having a first binding specificity, wherein said first antibody comprises an IgG4-like CH3 region, b) providing a second antibody having a second binding specificity which differs from said first binding specificity, wherein said second antibody comprises an IgG4-like CH3 region, c) incubating said first and second antibodies together under reducing conditions which allow the cysteines in the core hinge region to undergo disulfide-bond isomerization, and d) obtaining a bispecific antibody. The invention furthermore relates to bispecific antibodies obtainable by the method of the invention.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10906991 Bispecific antibodies and methods for production thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.